Safe at Any Cost?
On its face, the issue seems black and white: In issuing a compulsory license to import or produce the generic second-line HIV/AIDS drug efavirenz on November 29—two days before World AIDS Day—Thailand’s military government valiantly signaled its intentions to fend off pressure from Big Pharma and supply sick patients with affordable antiretrovirals.
Who…
Keep reading with a 7-day free trial
Subscribe to Asia Sentinel to keep reading this post and get 7 days of free access to the full post archives.